Tirzepatide is a synthetic dual-receptor agonist peptide developed for laboratory research into metabolic signaling pathways. It is structurally engineered to interact with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors in experimental models.
In research environments, tirzepatide is studied for its role in glucose regulation, energy balance, and metabolic pathway modulation. Its dual-agonist design differentiates it from single-receptor peptides and makes it a compound of interest in advanced metabolic research.
Tirzepatide is supplied in lyophilized (freeze-dried) form to maintain stability during storage and laboratory handling.
For research purposes only. Not for human consumption.
| Specification |
Detail |
| Compound Name |
Tirzepatide |
| Classification |
Synthetic dual GIP/GLP-1 receptor agonist peptide |
| Peptide Type |
Modified linear peptide |
| Molecular Formula |
C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight |
~4,814.9 g/mol |
| Amino Acid Length |
39 amino acids |
| Purity |
≥99% (HPLC verified) |
| Form |
Lyophilized powder |
| Quantity |
10 mg per vial |
| Solubility |
Soluble in aqueous solutions (research handling) |
| Testing |
HPLC / MS |
| COA |
Available per batch |
| Storage |
Store refrigerated (2–8 °C) or frozen for long-term stability |
